Syndax Pharmaceuticals In... (SNDX)
NASDAQ: SNDX
· Real-Time Price · USD
15.71
0.98 (6.65%)
At close: Aug 15, 2025, 3:59 PM
16.00
1.88%
After-hours: Aug 15, 2025, 07:56 PM EDT
Syndax Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 78.18M | 43.72M | 23.68M | 16.54M | 4.04M | 536K | 536K | n/a | n/a | n/a | n/a | 126.58M | 138.95M | 139.33M | 139.71M | 13.51M | 1.52M | 1.52M |
Cost of Revenue | 2.17M | 45.22M | 44.34M | 44.61M | 44.61M | 426K | 536K | 383K | 488K | 446K | 454K | 460K | 352K | 242K | 121K | 1K | 1K | 1K |
Gross Profit | 75.19M | -2.33M | -21.49M | -28.07M | -40.58M | 110K | n/a | -383K | -488K | -446K | -454K | 126.12M | 138.6M | 139.09M | 139.59M | 13.51M | 1.52M | 1.52M |
Operating Income | -339.05M | -343.92M | -339.67M | -321.21M | -287.99M | -263.45M | -229.95M | -194.08M | -172.87M | -160.91M | -151.76M | -13.97M | 1.14M | 16.52M | 26.22M | -89.39M | -89.21M | -83.49M |
Interest Income | 25.68M | 26.02M | 26.09M | 24.53M | 24.43M | 23.34M | 21.16M | 18.6M | 15.04M | 10.72M | 5.87M | 2.97M | 1.28M | 506K | 402K | 417K | 511K | 628K |
Pretax Income | -334.99M | -331.2M | -318.76M | -297.06M | -264.08M | -240.63M | -209.36M | -176.08M | -160.34M | -153.29M | -149.34M | -13.95M | 818K | 15.48M | 24.93M | -91.69M | -91.49M | -85.64M |
Net Income | -334.99M | -331.2M | -318.76M | -297.06M | -264.08M | -240.63M | -204.43M | -168.26M | -152.78M | -145.74M | -147.03M | -14.52M | 507K | 15.17M | 24.93M | -91.69M | -91.49M | -85.64M |
Selling & General & Admin | 153.63M | 138.89M | 120.88M | 105.97M | 92.13M | 77.98M | 66.92M | 54.34M | 45.31M | 38.38M | 33.26M | 29.99M | 28.55M | 26.41M | 25.24M | 23.03M | 22.06M | 22.26M |
Research & Development | 260.36M | 246.79M | 241.64M | 231.24M | 199.35M | 185.47M | 163.03M | 139.75M | 127.56M | 122.53M | 118.5M | 110.56M | 109.26M | 96.4M | 88.25M | 79.87M | 68.67M | 62.74M |
Other Expenses | 247K | 161K | -173K | -228K | -294K | -301K | -214K | -159K | -388K | -326K | -210K | -210K | 44K | 25K | -148K | -148K | -107K | -96K |
Operating Expenses | 415.07M | 386.75M | 363.35M | 337.21M | 291.48M | 263.45M | 229.95M | 194.08M | 172.87M | 160.91M | 151.76M | 140.55M | 137.82M | 122.81M | 113.49M | 102.9M | 90.73M | 85M |
Interest Expense | 4.64M | -3.17M | 4.93M | 186K | 233K | 223K | 208K | 188K | 1.87M | 2.53M | 3.14M | 3.09M | 2M | 1.93M | 1.91M | 2.54M | 2.53M | 2.53M |
Selling & Marketing Expenses | n/a | n/a | n/a | -21.36M | -21.36M | -21.36M | -21.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 417.23M | 387.64M | 363.35M | 337.21M | 291.49M | 263.45M | 229.95M | 194.08M | 172.87M | 160.91M | 151.76M | 140.55M | 137.82M | 122.81M | 113.49M | 102.9M | 90.73M | 85M |
Income Tax Expense | n/a | n/a | -40.28K | -40.28K | -43.28K | -101.28K | -4.99M | -7.88M | -7.61M | -7.55M | -2.31M | 563K | 301K | 301K | -10K | -21K | -44K | -44K |
Shares Outstanding (Basic) | 86.34M | 85.62M | 85.79M | 85.43M | 85.27M | 85.21M | 72.52M | 69.86M | 69.64M | 69.44M | 63.19M | 60.67M | 60.16M | 58.98M | 51.79M | 51.96M | 51.6M | 51.5M |
Shares Outstanding (Diluted) | 86.34M | 85.62M | 85.79M | 85.43M | 85.27M | 85.21M | 72.52M | 69.86M | 69.64M | 69.44M | 63.19M | 60.67M | 60.16M | 58.98M | 53.18M | 51.96M | 51.6M | 51.5M |
EPS (Basic) | -3.9 | -3.87 | -3.73 | -3.63 | -3.38 | -3.22 | -2.89 | -2.46 | -2.32 | -2.3 | -2.42 | -0.04 | 0.15 | 0.33 | 0.43 | -1.82 | -1.88 | -1.86 |
EPS (Diluted) | -3.9 | -3.87 | -3.73 | -3.63 | -3.38 | -3.22 | -2.89 | -2.46 | -2.32 | -2.3 | -2.42 | -0.04 | 0.15 | 0.33 | 0.43 | -1.82 | -1.88 | -1.86 |
EBITDA | -321.21M | -325.24M | -313.82M | -296.87M | -263.84M | -240.25M | -208.88M | -175.51M | -157.98M | -150.32M | -145.75M | -10.39M | 3.17M | 17.67M | 26.99M | -89.19M | -88.99M | -83.13M |
EBIT | -330.35M | -334.38M | -313.83M | -296.88M | -263.85M | -240.41M | -209.15M | -175.89M | -158.47M | -150.77M | -146.2M | -10.85M | 2.81M | 17.41M | 26.83M | -89.15M | -88.97M | -83.11M |
Depreciation & Amortization | 9.14M | 9.14M | 8K | 11K | 12K | 161K | 271K | 383K | 488K | 446K | 454K | 460K | 465K | 460K | 456K | 356K | 266K | 183K |